These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 13049572)

  • 1. The concentration of PAS in the blood during medication with PAS or PAS-salts.
    NILSSON H
    Tubercle; 1953 Apr; 34(4):100-4. PubMed ID: 13049572
    [No Abstract]   [Full Text] [Related]  

  • 2. [PAS concentration in blood in therapeutic use of PAS and its salts].
    NILSSON H
    Sven Lakartidn; 1952 Apr; 49(16):1044-50. PubMed ID: 14958642
    [No Abstract]   [Full Text] [Related]  

  • 3. [On PAS calcium salts].
    SMOLAREK W
    Tuberkulosearzt; 1953 May; 7(5):303-5. PubMed ID: 13090340
    [No Abstract]   [Full Text] [Related]  

  • 4. A micro-method for the determination of paraaminosalicylic acid (aminosallyl) PAS and n-acetyl-para-aminosalicylic acid (acetyl-PAS).
    NIELSEN E; PRAETORIUS E
    Scand J Clin Lab Invest; 1952; 4(4):313-8. PubMed ID: 13048610
    [No Abstract]   [Full Text] [Related]  

  • 5. Para-aminosalicylic-acid (PAS) concentrations in the serum during treatment with various PAS preparations.
    CITRON KM; KUPER SW
    Tubercle; 1959 Dec; 40():443-52. PubMed ID: 13693755
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of blood levels of para-aminosalicylic acid (PAS) in tuberculous patients treated with various PAS preparations.
    BANG HO; STRANDGAARD E
    Acta Tuberc Scand; 1957; 34(1-2):58-75. PubMed ID: 13508356
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapy of tuberculosis with p-aminosalicylic acid; experimental studies on PAS and sodium-PAS blood level after administration].
    KOELZER PP; WEHR KH; GIESEN J
    Arztl Forsch; 1953 Jul; 7(7):I/336-44. PubMed ID: 13091943
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative concentration of PAS in blood following oral administration of PAS alone and with vitamin C].
    NEDELJKOVIC J; DUGANDZIC S; DUGANDZIC M; TUCAKOVIC M
    Vojnosanit Pregl; 1954; 11(9-10):372-6. PubMed ID: 13226731
    [No Abstract]   [Full Text] [Related]  

  • 9. [PAS blood content after peroral intake of different calcium-PAS-granulates].
    SANZ MC; MULLER A
    Schweiz Med Wochenschr; 1952 Dec; 82(52):1334-5. PubMed ID: 13028219
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma concentrations of para-aminosalicylic acid (PAS) after oral and rectal administration as influenced by p-(di-n-propylsulfamyl)-benzoic acid (benemid).
    RIEBER CW; SALINE M; FRIEDMAN MM
    Am Rev Tuberc; 1951 Oct; 64(4):448-52. PubMed ID: 14885675
    [No Abstract]   [Full Text] [Related]  

  • 11. Continued studies in concentrations of para-amino-salicylic acid (PAS) in the blood.
    FROSTAD S
    Acta Tuberc Pneumol Scand; 1961; 41():68-82. PubMed ID: 13895556
    [No Abstract]   [Full Text] [Related]  

  • 12. [Retarding effect of butazolidine on the elimination of PAS].
    CURCHOD B; CHENET C; VIELHAUER S
    Schweiz Z Tuberk; 1954; 11(3):175-84. PubMed ID: 13205179
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oral administration of PAS].
    RENARD J; COULET M; RIMBAULT Y
    Therapie; 1952; 7(4):362-7. PubMed ID: 12984373
    [No Abstract]   [Full Text] [Related]  

  • 14. [Paper electrophoretic study of binding of PAS with blood proteins].
    WIEDERMANN D; TOVAREK J
    Lek List; 1954 Jun; 9(12):270-1. PubMed ID: 13213205
    [No Abstract]   [Full Text] [Related]  

  • 15. The blood level determinations of PAS and isoniazid with vanillin.
    DEEB EN; VITAGLIANO GR
    J Am Pharm Assoc Am Pharm Assoc; 1955 Mar; 44(3):182-5. PubMed ID: 14353748
    [No Abstract]   [Full Text] [Related]  

  • 16. Brain regional pharmacokinetics of p-aminosalicylic acid and its N-acetylated metabolite: effectiveness in chelating brain manganese.
    Hong L; Jiang W; Pan H; Jiang Y; Zeng S; Zheng W
    Drug Metab Dispos; 2011 Oct; 39(10):1904-9. PubMed ID: 21768272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.
    Rengarajan J; Sassetti CM; Naroditskaya V; Sloutsky A; Bloom BR; Rubin EJ
    Mol Microbiol; 2004 Jul; 53(1):275-82. PubMed ID: 15225321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical pharmacokinetics of para-aminosalicylic acid tablets].
    Miroshnichenko II; Sokolova GB; Mokhireva LV
    Antibiot Khimioter; 2009; 54(1-2):20-4. PubMed ID: 19499713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modifications of gastric function induced by PAS and its salts].
    FORATTINI C; SELMI W
    Arch Tisiol Mal Appar Respir; 1951 Nov; 6(11):939-47. PubMed ID: 14915785
    [No Abstract]   [Full Text] [Related]  

  • 20. Elimination of para-aminosalicylic acid in patients with liver disease and renal insufficiency.
    Held H; Fried F
    Chemotherapy; 1977; 23(6):405-15. PubMed ID: 923330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.